Search

everythinglearnresearchcommunity

for

Search:↓

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

A new mutation in the AGPAT2 gene causes severe fat tissue loss and related health issues by reducing the protein's levels.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Zinc supplements improved hair and skin conditions in two patients.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Skin symptoms can indicate endocrine disorders and have various treatments.

A horse in Brazil had seasonal hair loss possibly linked to light exposure and melatonin levels.

Men with more severe hair loss had a lower risk of schizophrenia, but hair loss and testosterone levels were not linked.

Finasteride may help some women with hair loss, but better options exist.

Trichoscopy is a useful tool for diagnosing hair disorders without pulling out hair.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Some congenital hair disorders improve in childhood or with treatments like minoxidil and retinoids, while others like Netherton syndrome and trichothiodystrophy have a poor prognosis.

No cure exists for alopecia areata, and treatments are personalized.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Low IGF-1 and high HDL cholesterol levels are linked to more hair loss in middle-aged women.

PRP helps with skin, hair, and wound treatments but needs more research for standard use.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Early signs of PCOS in girls, like irregular periods and polycystic ovaries, suggest a need for early diagnosis and intervention to prevent further health issues.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Androgens and other hormones affect hair growth and skin conditions like acne.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.